首页> 美国卫生研究院文献>The Oncologist >The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

【2h】

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

机译：在弥漫性大型B细胞淋巴瘤的试验中寻找替代终点：侵略性淋巴瘤项目的替代终点

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

机译：该评论描述了SEAL（侵袭性淋巴瘤的替代终点）研究小组的进展，并邀请共享数据方面的合作以继续建立来自DLBCL多个临床试验的单个患者数据的大型数据库。

著录项

期刊名称 The Oncologist
作者
Daniel J. Sargent; Qian Shi; *; Christopher R. Flowers; Norbert Schmitz; Thomas M. Habermann; Jocelyne Flament; Tommy Fu; Bertrand Coiffier;
展开▼
作者单位

展开▼
年(卷),期 2017(22),12
年度 2017
页码 1415–1418
总页数 4
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Biomarkers Clinical trials Diffuse large B‐cell lymphoma Individual patient data Meta‐database Surrogate endpoints;

机译：生物标志物;临床试验;弥漫性大B细胞淋巴瘤;个体患者数据;元数据库;替代终点;

相似文献

外文文献
中文文献
专利

1. The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project [J] . Sargent Daniel J., Shi Qian, Flowers Christopher R., The oncologist . 2017 ,第12期

机译：在弥漫性大B细胞淋巴瘤的试验中寻找替代终点：侵袭性淋巴瘤项目的替代终点
2. Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma [J] . Wudhikarn Kitsada, Bunworasate Udomsak, Julamanee Jakrawadee, Hematological oncology . 2019 ,第S2期

机译：24个月的事件自由生存是外周T细胞淋巴瘤的强烈替代替代预后终点
3. Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma [J] . Wudhikarn Kitsada, Bunworasate Udomsak, Julamanee Jakrawadee, Hematological oncology . 2019 ,第5期

机译：24个月的事件自由生存是外周T细胞淋巴瘤的强烈替代替代预后终点
4. Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities [C] . B.K. Dunn and P. GreenwaldK. Jegalian International Conference on Clinical Cancer Prevention . 2011

机译：早期检测和癌症预防试验中的替代终点的生物标志物：问题和机遇
5. Statistical methods for identifying surrogate endpoints in vaccine trials. [D] . Wolfson, Julian. 2009

机译：在疫苗试验中识别替代终点的统计方法。
6. The search for surrogate endpoints for immunotherapy trials [O] . Marc Buyse, Tomasz Burzykowski, Everardo D. Saad 2018

机译：寻找免疫疗法试验的替代终点
7. POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL. [O] . S. Luminari, L. Marcheselli, M. Manni, 2017

机译：POD24和CR30是有前途的替代端点，用于评估在FOLL05试验中注册的晚期卵泡淋巴瘤患者的患者的结果。

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

摘要

著录项

相似文献

相关主题

期刊订阅